NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
Clinical trial condition
Bacterial Infections
Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.
4,522 public trials
496 recruiting studies
Bacterial Infections trial results
Completed
Scrub Typhus RDT Study
NCT03269266
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- No.20, 100 Bedded Military Hospital, Thabeikkyin, Mandalay Region, Burma
- No.2, 1000 Bedded Military Hospital Nay Pyi Taw, Burma
NCT03950986
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
- Locations
-
- Atlanta VA Medical Center Decatur, Georgia, United States
NCT02786576
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
- Locations
-
- Krankenanstalt Rudolfstiftung /ID# 166804 Vienna, State of Vienna, Austria
- LKH-Univ. Klinikum Graz /ID# 166802 Graz, Austria
- Klinikum Wels - Grieskirchen /ID# 158017 Wels, Austria
- UZ Brussel /ID# 154218 Jette, Brussels Capital, Belgium
NCT03091777
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Bacterial Vaginosis, +9 more
- Locations
-
- Site 103 Raleigh, North Carolina, United States
NCT00352963
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Alcorcón, Spain
- GSK Investigational Site Almeira, Spain
- GSK Investigational Site Badalona, Spain
- GSK Investigational Site Barcelona, Spain
NCT00609492
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Athens, Greece
- GSK Investigational Site Athens, Greece
- GSK Investigational Site Ioannina, Greece
- GSK Investigational Site Thessaloniki, Greece
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT00970307
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
NCT00814710
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Kolkata, India
- GSK Investigational Site Ludhiana, India
- GSK Investigational Site Pune, India
- GSK Investigational Site Vellore, India